Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Oct 12, 16:00
Forte Biosciences EPS Diluted (TTM) : -5.130 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.130 |
| March 31, 2026 | -5.107 |
| December 31, 2025 | -5.239 |
| September 30, 2025 | -4.444 |
| June 30, 2025 | -7.992 |
| March 31, 2025 | -13.81 |
| December 31, 2024 | -16.47 |
| September 30, 2024 | -19.39 |
| June 30, 2024 | -21.42 |
| March 31, 2024 | -25.21 |
| December 31, 2023 | -29.22 |
| September 30, 2023 | -30.98 |
| June 30, 2023 | -28.90 |
| March 31, 2023 | -23.47 |
| December 31, 2022 | -19.78 |
| September 30, 2022 | -19.64 |
| June 30, 2022 | -28.76 |
| March 31, 2022 | -34.30 |
| December 31, 2021 | -39.01 |
| September 30, 2021 | -42.27 |
| Date | Value |
|---|---|
| June 30, 2021 | -40.03 |
| March 31, 2021 | -267.41 |
| December 31, 2020 | -282.57 |
| September 30, 2020 | -292.20 |
| June 30, 2020 | -289.01 |
| March 31, 2020 | -58.42 |
| December 31, 2019 | -312.25 |
| September 30, 2019 | -653.10 |
| June 30, 2019 | -652.12 |
| March 31, 2019 | -948.40 |
| December 31, 2018 | -912.99 |
| September 30, 2018 | -759.84 |
| June 30, 2018 | -940.14 |
| March 31, 2018 | -846.39 |
| December 31, 2017 | -2145.00 |
| September 30, 2017 | -3310.33 |
| June 30, 2017 | -3321.58 |
| March 31, 2017 | -3111.58 |
| June 30, 2016 | -1570.33 |
| March 31, 2016 | -198.75 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| argenx SE | 26.24 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |
| Anika Therapeutics, Inc. | -0.2741 |
| Savara, Inc. | -0.5766 |